Citation: J. Vavrova et al., Radiation-induced apoptosis and cell cycle progression in TP53-deficient human leukemia cell line HL-60, NEOPLASMA, 48(1), 2001, pp. 26-33
Authors:
Vanasek, J
Filip, S
Medkova, V
Blaha, M
Mericka, P
Stransky, P
Vavrova, J
Citation: J. Vanasek et al., Intensive cyclic chemotherapy with unprocessed whole blood support in advanced breast cancer, NEOPLASMA, 48(1), 2001, pp. 34-38
Authors:
Filip, S
Blaha, M
Petera, J
Vavrova, J
Knizek, J
Citation: S. Filip et al., Peripheral progenitor cells (PBPC) in supportive care after high-dose chemotherapy in breast cancer, NEOPLASMA, 48(1), 2001, pp. 39-47
Authors:
Filip, S
Blaha, M
Odrazka, K
Mericka, P
Vavrova, J
Citation: S. Filip et al., Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer, J HEMATH ST, 9(1), 2000, pp. 31-38
Authors:
Filip, S
Vavrova, J
Vokurkova, D
Blaha, M
Vanasek, J
Citation: S. Filip et al., Myeloid differentiation and maturation of SCF+IL-3+IL-11 expanded AC133(+)/CD34(+) cells selected from high-risk breast cancer patients, NEOPLASMA, 47(2), 2000, pp. 73-80
Authors:
Vavrova, J
Filip, S
Vokurkova, D
Blaha, M
Vanasek, T
Jebavy, L
Citation: J. Vavrova et al., Ex vivo expansion CD34(+)/AC133(+) - selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy, HEM CELL TH, 41(3), 1999, pp. 105-112
Authors:
Adamcova, M
Gersl, V
Hrdina, R
Melka, M
Mazurova, Y
Vavrova, J
Palicka, V
Kokstein, Z
Citation: M. Adamcova et al., Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits, J CANC RES, 125(5), 1999, pp. 268-274
Authors:
Filip, S
Vanasek, J
Blaha, J
Mericka, P
Vavrova, J
Podzimek, K
Citation: S. Filip et al., The increase of the rate of hemopoietic recovery and clinical benefit of the erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients, NEOPLASMA, 46(3), 1999, pp. 166-172